secwatch.observer — SEC 8-K summary
======================================

Issuer:     Medicus Pharma Ltd. (MDCX)
CIK:        0001997296
Form:       8-K
Filed at:   2025-07-14T23:59:59+00:00
Accession:  0001062993-25-012767
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Medicus Pharma enters warrant inducement for $3.75M gross; also sells $1.52M shares via SEPA
--------------------------------------------------------------------------------

- Holder exercises 1.34M existing warrants at $2.80; receives 2.68M new warrants at $3.75 expiring in 5 years.
- Gross proceeds from warrant exercise ~$3.75M; net used for clinical trials, working capital, and Antev acquisition costs.
- Company sold 490,000 common shares to Yorkville via SEPA for net proceeds of ~$1.52M at ~$3.10/share.
- Maxim Group LLC receives 6.0% cash fee on warrant exercise gross proceeds.
- Company to file S-1 registration for resale of new warrant shares within 120 days.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1997296/000106299325012767/0001062993-25-012767-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1997296/000106299325012767/form8k.htm
  HTML page:      https://secwatch.observer/filing/0001062993-25-012767

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer